StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Neogen cash

Cash and short-term investments held at the end of each period.

Neogen's cash was $172.00M at Aug 31, 2026. For fiscal 2026 it was $185.50M, up 43.8% from the year before. Over ten years it grew 5.6% a year on average. The highest annual figure on record is $381.09M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2026May 31, 2026$185.50M+43.8%
FY2025May 31, 2025$129.00M-24.5%
FY2024May 31, 2024$170.93M-30.4%
FY2023May 31, 2023$245.53M-35.6%
FY2022May 31, 2022$381.05M-0.0%
FY2021May 31, 2021$381.09M+10.9%
FY2020May 31, 2020$343.67M+28.5%
FY2019May 31, 2019$267.52M+26.9%
FY2018May 31, 2018$210.81M+46.8%
FY2017May 31, 2017$143.64M+33.2%
FY2016May 31, 2016$107.80M-5.6%
FY2015May 31, 2015$114.16M+49.2%
FY2014May 31, 2014$76.50M-10.4%
FY2013May 31, 2013$85.37M+24.4%
FY2012May 31, 2012$68.65M+22.4%
FY2011May 31, 2011$56.08M+145.9%
FY2010May 31, 2010$22.81M+64.8%
FY2009May 31, 2009$13.84M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$172.00M+23.9%
Q4 FY2026CQ2 2026May 31, 2026$185.50M+43.8%
Q3 FY2026CQ1 2026Feb 28, 2026$159.90M+25.2%
Q2 FY2026CQ4 2025Nov 30, 2025$145.34M+3.6%
Q1 FY2026CQ3 2025Aug 31, 2025$138.80M+15.2%
Q4 FY2025CQ2 2025May 31, 2025$129.00M-24.5%
Q3 FY2025CQ1 2025Feb 28, 2025$127.70M-24.2%
Q2 FY2025CQ4 2024Nov 30, 2024$140.23M-24.6%
Q1 FY2025CQ3 2024Aug 31, 2024$120.48M-49.6%
Q4 FY2024CQ2 2024May 31, 2024$170.93M-30.4%
Q3 FY2024CQ1 2024Feb 29, 2024$168.45M-8.1%
Q2 FY2024CQ4 2023Nov 30, 2023$185.94M-32.7%
Q1 FY2024CQ3 2023Aug 31, 2023$239.26M-31.2%
Q4 FY2023CQ2 2023May 31, 2023$245.53M-35.6%
Q3 FY2023CQ1 2023Feb 28, 2023$183.21M-51.6%
Q2 FY2023CQ4 2022Nov 30, 2022$276.34M-29.0%
Q1 FY2023CQ3 2022Aug 31, 2022$347.71M-13.3%
Q4 FY2022CQ2 2022May 31, 2022$381.05M-0.0%
Q3 FY2022CQ1 2022Feb 28, 2022$378.44M+7.1%
Q2 FY2022CQ4 2021Nov 30, 2021$389.25M-0.4%
Q1 FY2022CQ3 2021Aug 31, 2021$400.88M+9.1%
Q4 FY2021CQ2 2021May 31, 2021$381.09M+10.9%
Q3 FY2021CQ1 2021Feb 28, 2021$353.35M+7.8%
Q2 FY2021CQ4 2020Nov 30, 2020$390.77M+24.6%
Q1 FY2021CQ3 2020Aug 31, 2020$367.49M+26.3%
Q4 FY2020CQ2 2020May 31, 2020$343.67M+28.5%
Q3 FY2020CQ1 2020Feb 29, 2020$327.92M+32.9%
Q2 FY2020CQ4 2019Nov 30, 2019$313.61M+30.1%
Q1 FY2020CQ3 2019Aug 31, 2019$291.02M+28.5%
Q4 FY2019CQ2 2019May 31, 2019$267.52M+26.9%
Q3 FY2019CQ1 2019Feb 28, 2019$246.68M+28.4%
Q2 FY2019CQ4 2018Nov 30, 2018$240.97M+37.0%
Q1 FY2019CQ3 2018Aug 31, 2018$226.41M+41.5%
Q4 FY2018CQ2 2018May 31, 2018$210.81M+46.8%
Q3 FY2018CQ1 2018Feb 28, 2018$192.16M+54.2%
Q2 FY2018CQ4 2017Nov 30, 2017$175.84M+23.7%
Q1 FY2018CQ3 2017Aug 31, 2017$159.99M–
Q4 FY2017CQ2 2017May 31, 2017$143.64M–
Q3 FY2017CQ1 2017Feb 28, 2017$124.58M–
Q2 FY2017CQ4 2016Nov 30, 2016$142.11M–

More Neogen figures

See a number that looks wrong?